Skip to main content
. 2022 Aug 22;10(8):1370. doi: 10.3390/vaccines10081370

Figure 2.

Figure 2

This figure overviews the epigenetic and predictive biomarkers, various immune checkpoint inhibitors, immunotherapies, and combination immunotherapeutic approaches implicated in prostate cancer.